Tech Company Financing Transactions
FluGen Funding Round
On 8/21/2015, FluGen received $9.4 million in financing from private investors.
Transaction Overview
Company Name
Announced On
8/21/2015
Transaction Type
Venture Equity
Amount
$9,423,860
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
597 Science Dr.
Madison, WI 53711
USA
Madison, WI 53711
USA
Phone
Website
Email Address
Overview
FluGen is driving the development of a universal flu vaccine to advance human health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Radspinner
Chief Scientific Officer
Pamuk Bilsel
VP - R & D
Renee Herber
Browse more venture capital transactions:
Prev: 8/21/2015: Kinvolved venture capital transaction
Next: 8/21/2015: Vurb venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs